SuPine Therapeutics Inc., a UNIST-based biotech venture founded by Professor Jeong Beom Kim in the Department of Life Sciences at UNIST has recently been honored with the commendation from the Ministry of SMEs and Startups (MSS) at the 2022 Ulsan Startup Festa, which took place on November 30, 2022.
The award was directly related to his recent research and development efforts in finding prospective cures for the patients with spinal cord injury (SCI), and thus contributing to the development of Korean society through the establishment of SuPine Therapeutics Inc.
Starting with the screening of the opening video under the theme of “Engraving the Spirit of Entrepreneurs,” the event was held in the following orders of the opening performance, awarding of commendations, as well as a tour of the exhibition hall. At the award presentation ceremony, Professor Jeong Beom Kim, founder of SuPine Therapeutics Inc., received the commendation from the Ministry of SMEs and Startups, while President Min-Ki Kim of Cheongmyeong Advanced Materials Co., Ltd.) was given the commendation for startup merit.
A new spinal-cord treatment developed by SuPine Therapeutics Inc. has shown excellent therapeutic effects in animal models of SCI, is pushing for good manufacturing practice (GMP) to perform clinical trials, and is actively carrying out licensing procedures to obtain approval from the Ministry of Food and Drug Safety (MFDS) and the U.S. Food and Drug Administration (FDA).
“I am deeply honored to receive this prestigious award,” said Professor Kim. “Special thanks to UNIST and everyone who supported me from the moment I started my own business.” He adds, “We will do our utmost to translate research findings into real-world clinical practice.”